| Literature DB >> 35814190 |
Moses Egesa1,2,3, Agnes Ssali4, Edward Tumwesige4, Moses Kizza1, Emmanuella Driciru1, Fiona Luboga2, Meta Roestenberg4,5, Janet Seeley4,6, Alison M Elliott1,7.
Abstract
Issues related to controlled human infection studies using Schistosoma mansoni (CHI-S) were explored to ensure the ethical and voluntary participation of potential CHI-S volunteers in an endemic setting in Uganda. We invited volunteers from a fishing community and a tertiary education community to guide the development of informed consent procedures. Consultative group discussions were held to modify educational materials on schistosomiasis, vaccines and the CHI-S model and similar discussions were held with a test group. With both groups, a mock consent process was conducted. Fourteen in-depth key informant interviews and three group discussions were held to explore perceptions towards participating in a CHI-S. Most of the participants had not heard of the CHI-S. Willingness to take part depended on understanding the study procedures and the consenting process. Close social networks were key in deciding to take part. The worry of adverse effects was cited as a possible hindrance to taking part. Volunteer time compensation was unclear for a CHI-S. Potential volunteers in these communities are willing to take part in a CHI-S. Community engagement is needed to build trust and time must be taken to share study procedures and ensure understanding of key messages.Entities:
Keywords: Controlled human infection; endemic; informed consent; perceptions; schistosomiasis
Year: 2022 PMID: 35814190 PMCID: PMC9258062 DOI: 10.1080/11287462.2022.2091503
Source DB: PubMed Journal: Glob Bioeth ISSN: 1128-7462
Figure 1.Study flow. The activities were conducted in each of the two target communities.
Test of comprehension results for the communities (N = 40).
| Question topic | Fishing community | University community | Total Score per question | ||||
|---|---|---|---|---|---|---|---|
| Consultative group | Test group | Score | Consultative group | Test group | Score | ||
| 1. Where do we get schistosomiasis from? | 10 | 12 | 22 (88) | 9 | 5 | 14 (93) | 36 (90) |
| 2. Can schistosomiasis be stopped by minimising contact with infested water? | 11 | 12 | 23 (92) | 9 | 5 | 14 (93) | 37 (93) |
| 3. Could a vaccine prevent schistosomiasis? | 12 | 11 | 23 (92) | 10 | 5 | 15 (100) | 38 (95) |
| 4. What are the characteristics of a controlled human infection study? | 5 | 7 | 12 (48) | 7 | 3 | 10 (66) | 22 (55) |
| 5. Is determining the number of larvae to safely use on volunteers the first step in CHI-S? | 10 | 9 | 19 (76) | 10 | 4 | 14 (93) | 33 (83) |
| 6. What is involved in testing a vaccine using controlled human infection? | 10 | 6 | 16 (64) | 5 | 2 | 7 (47) | 23 (58) |
| 7. Why do volunteers come into the clinic every week after infection [CHI-S]? | 10 | 4 | 14 (56) | 3 | 3 | 6 (40) | 20 (50) |
| 8. Could a controlled human infection with | 12 | 11 | 23 (92) | 10 | 4 | 14 (93) | 37 (93) |
| 9. What does a volunteer need to do before he/she can participate in the study? | 11 | 6 | 17 (68) | 9 | 5 | 14 (93) | 31 (78) |
| 10. Do volunteers personally benefit from participating in CHI? | 3 | 6 | 9 (36) | 4 | 4 | 8 (53) | 17 (43) |
| Total score per group, | 94 (78) | 84 (65) | 178 (71) | 76 (76) | 40 (80) | 116 (77) | |
The percentage is the number of participants with correct answers divided by the total number of participants (i.e. 40).
The percentage is the number of correct answers divided by the possible total of correct answers for each group in each setting.
Sociodemographic characteristics of the participants in GDs and KIIs (N = 33).
| University community | Fishing community | |||
|---|---|---|---|---|
| Characteristic | Consultative group | Test group | Consultative group | Test group |
| Sex | ||||
| Females ( | 3 | 2 | 6 | 5 |
| Age (range) | ||||
| 18–35 | 5 | 1 | 7 | 4 |
| 36–50 | 1 | 2 | 2 | 7 |
| Over 50 | 1 | 1 | 1 | 1 |